Connect with us
Spain's medical cannabis production grew 42.5% in 2024, reaching 51.3 tons, despite lacking domestic regulation. Licensed for export, the sector generates €500 million annually, driven by...
Cannabis legalization in the U.S. is linked to reduced benzodiazepine prescriptions, as a study in JAMA Network Open shows patients opt for cannabis to manage anxiety...
Philip Morris partners with Avicanna, leveraging Canada’s regulated cannabis market to expand into medical cannabis. Unlike competitors targeting recreational cannabis, PMI emphasizes patient care, research, and...
Berlin’s Green Leaf Society, the city’s first legal cannabis cooperative, distributes ten grams monthly to members for €89, with additional purchases possible. Approved for indoor cultivation,...
Cannabis use among youth is rising globally, driven by increased legalization. Early use, before age 16, disrupts brain development, impairing memory, decision-making, and reward processing. It...
Studies confirm cannabis legalization decreases youth use. In Colorado, teen cannabis use dropped 35% since 2012. Washington saw declines of 58%–61% among students. National data mirrors...
Israel, a global cannabis industry leader, faces a severe market crisis. In 2024, active cannabis companies dropped from 52 to 47, and available products fell from...
The regulations on low-THC cannabis and the recent changes to the law related to the decriminalization of possession and cultivation are an important step towards the...
The DEA will begin cannabis rescheduling on January 21, potentially lowering its classification to Schedule III for medical prescriptions. However, Trump’s presidency and Republican majorities dim...
New regulations in Poland require in-person doctor visits for medical cannabis prescriptions, leading to a sharp drop from 68,000 in October 2024 to 28,000 by December....